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Abstract
Background: Stuck mechanical heart valves had a debate about the management plan. There is debate regarding the
type, dose, and rate of administration of various thrombolytic agents. We report a case with successful thrombolysis
using an ultraslow regimen.
Case summary: A 43-year-old female with a history of aortic valve (AV) and mitral valve replacement (bi-leaﬂet metallic
valves), and tricuspid valve repair (MINI band) at October 2017. Physical examination showed normal metallic ﬁrst heart
sound and weak metallic second heart sound. Laboratory investigations were normal except low INR, hematocrit, and
hemoglobin level (9 gm/L due to iron deﬁciency anemia). Transthoracic echocardiogram (TTE) and Transoesophageal
echocardiogram (TEE) conﬁrmed stuck aortic valve leaﬂet, with a high mean pressure gradient across prosthetic AV
(34 mmHg). The mechanical mitral valve was working well. Fluoroscopy showed stuck one of the AV leaﬂets in a closed
position. The treating physician decided to give her the chance for thrombolytic therapy. This case was treated with
ultraslow thrombolytic therapy (Alteplase, 1 mg, every hour) with follow up transthoracic echocardiogram every 24 h to
check the pressure gradient on the AV. She was young, asymptomatic, and hemodynamically stable. After 48 h of
Alteplase, the stuck leaﬂet was released. The mean pressure gradient dropped to 16 mmHg.
Discussion: Ultraslow thrombolytic regimen advised to be tried in stuck mechanical valves and hemodynamically
stable patients.
Keywords: Stuck, Mechanical valve, Aortic, Thrombolytic, Case report

1. Introduction

S

trict adherence to oral anticoagulation is one
of the major limitations of prosthetic valves.
The rate of prosthetic valve thrombosis (PVT) was
estimated to be between 0.03% and 0.13% per
patient-year [1]. The mortality rates reported
being from 6% to 69% (average 12%) [2,3]. Multiple thrombolytic regimens have been developed
to improve the outcome. There is debate
regarding the type, dose, and rate of administration of various thrombolytic agents. There is no

clear consensus about the predictors of thrombolytic therapy complications especially major
bleeding. Direct comparison of ﬁbrinolysis with
surgery is difﬁcult, so, current guidelines depend
on expert opinions and non-randomized trials
with no class IA recommendations being given.
AHA/ACC 2017 guidelines mentioned that slowinfusion ﬁbrinolytic therapy has higher success
rates and lower complication rates than prior
high-dose regimens and is effective in patients
previously thought to require urgent surgical
intervention [4]. ESC/EACTS 2017 guidelines
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Fig. 1. A: TTE parasternal long-axis view, note the ﬂow acceleration at the lower half of the AV while no ﬂow in the upper half. B: TEE LVOT view at
130 degrees, note the accelerated ﬂow in the upper part of AV. C: TEE modiﬁed long axis view showed the color ﬂow only from one half of the AV. D:
X-plan at LVOT showed one moving AV leaﬂet.

mentioned that urgent or emergency valve
replacement is recommended for obstructive
thrombosis in critically ill patients without serious
comorbidity, I C. Fibrinolysis should be considered when surgery is not available or is very high
risk, II a C [5]. Society of Heart Valve Disease has
recommended ﬁbrinolysis as ﬁrst-line therapy in
the absence of a contraindication [6]. We present
a case of successful thrombolysis of stuck aortic
valve using the ultraslow infusion of alteplase.

2. Case description
A 43-year-old female patient with a history of
rheumatic heart disease causing aortic valve (AV)
and mitral valve (MV) stenosis which was treated
with AV and MV replacement (bi-leaﬂet metallic
valves), and tricuspid valve repair (MINI band) at
October 2017. She had persistent atrial ﬁbrillation.
The patient had a history of left leg embolectomy in
2017 and history of old left atrial appendage
thrombus. The patient was admitted from the
outpatient clinic due to a sub-therapeutic international normalized ratio (INR: 1.48) because the patient was missing her follow up appointments.

Physical examination showed alert and oriented
patient, looked well, not dyspneic or tachycardic,
vitally stable, pulse was 69 b/min and irregular.
Cardiological examination showed normal metallic
ﬁrst heart sound and weak metallic second heart
sound. There were ejection systolic murmur grade
III/VI and no additional sounds. The chest was clear
and there was no lower limb edema.
Laboratory investigations were normal except for
low INR, hematocrit, and hemoglobin level (9 gm/L
due to iron deﬁciency anemia). The electrocardiogram showed controlled atrial ﬁbrillation.
On TTE parasternal long-axis view, ﬂow acceleration at the lower half of the AV was seen, while no
ﬂow was seen in the upper half (Fig. 1A). On TEE
left ventricular outﬂow tract (LVOT) view showed
accelerated ﬂow in the upper part of AV (Fig. 1B),
and on modiﬁed long axis view the color ﬂow was
only from one half of the AV (Fig. 1C). X-plan at
LVOT showed one moving AV leaﬂet (Fig. 1D).
Fluoroscopy conﬁrmed this diagnosis clarifying
stuck one of the AV leaﬂets in a closed position
(Fig. 2A). However, ﬂuoroscopy will not be helpful
in identifying non-obstructive PVT or differentiating
pannus from thrombus [7]. Continuous doppler
ﬂow on AV showed the mean PG of 34 mmHg
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Fig. 2. A: Fluoroscopy showed stuck one of the AV leaﬂets in a closed position. B: Continuous doppler ﬂow on AV, the mean PG is 34 mmHg. C: After
48 h of Alteplase the stuck leaﬂet was released.

(Fig. 2B). The heart team meeting opinion divided,
some advised open heart surgery for AVR while
others advised thrombolytic therapy. The cardiac
surgeon was ready to take the patient to the operation room for aortic valve replacement. The treating physician decided to give her the chance for
thrombolytic therapy. This case was treated with
ultraslow thrombolytic therapy (Alteplase, 1 mg,
every one hour) with follow up transthoracic echocardiogram every 24 h to check the pressure
gradient on the AV. She was young, asymptomatic,
and hemodynamically stable. After 48 h of Alteplase, the stuck leaﬂet was released (Fig. 2C).
The transthoracic parasternal long-axis view
showed the color ﬂow acceleration through both AV
leaﬂets (Fig. 3A). The mean pressure gradient
dropped to 16 mmHg. (Fig. 3B).
The patient discharged and follow up TTE after 3
months showed a normally functioning both mechanical valves.

3. Discussion
It is strange for the high ﬂow aortic valve to be stuck
while the low ﬂow MV is normal. Although this is
infrequent situation, it is reported in many cases
including our case. The most common cause of

mechanical valve dysfunction is thrombosis especially in the setting of low INR. In the mechanical AV,
it is difﬁcult to visualize the thrombus by echocardiogram but we can expect the presence of thrombus
from leaﬂet stuck in closed or opened position.
Karthikeyan et al. searched EMBASE and MEDLINE up to 2012 and included seven eligible studies
with 690 episodes of PVT, 446 treated with surgery,
and 244 with ﬁbrinolytic therapy (FT). They
concluded that urgent surgery was not superior to
ﬁbrinolytic therapy at restoring valve function, but
substantially reduced the occurrence of thromboembolic events, major bleeding, and recurrent PVT
[8]. However, those results need to be conﬁrmed
with randomized controlled trials.
The problem with thrombolytic therapy is the
complications mainly the bleeding and thromboembolism. The theory was if we lower the dose of
the thrombolytic agent and prolong the duration of
infusion, we may decrease the complication rates to
be lower than surgical intervention. TROIA trial
enrolled 182 patients with PVT and compared 5
different thrombolytic regimens [9]. The endpoints
were a thrombolytic success, in-hospital mortality,
and nonfatal complication rates. TROIA investigators concluded that Low-dose slow infusion
of t-PA repeated as needed without a bolus provides

Fig. 3. A: TTE after 2 days showed the color ﬂow from both AV leaﬂets. B: The mean PG across mechanical AV decreased to 16 mmHg.

effective and safe thrombolysis in patients with
prosthetic valve thrombosis [9].
The Ultra-slow PROMETEE trial enrolled 114 patients with PVT. Ultraslow infusion (25 h) of low-dose
(25 mg) t-PA, as the FT regimen, was used in all patients. The overall success rate of FT was 90%. The
overall complication rate was 6.7% (3.3% nonfatal
major, 2.5% minor, and 0.8% death). The predictors of
complications were the presence of atrial ﬁbrillation,
higher NYHA class, and thrombus area [10]. They
concluded that Ultraslow (25 h) infusion of low-dose
(25 mg) t-PA without bolus appears to be associated
with quite low nonfatal complications and mortality
for PVT patients without loss of effectiveness, except
for those with NYHA class IV [10]. The PROMETTE
investigators hypothesized that further prolongation
of the FT regimen could be associated with lower
complication rates. Ultraslow dose thrombolytic
therapy can be given up to 8 days as soon as the patient is stable. Failure of thrombolysis is considered if
the leaﬂet remained stuck after 8 days. After thrombolysis failure, surgery should be the only option.
This case is consistent with most of those trials.
We recommend starting an ultraslow regimen of
thrombolysis for stuck mechanical valves in hemodynamically stable patients.
Conclusion: Ultraslow thrombolytic regimen
should be tried for stuck mechanical heart valves
before surgery in hemodynamically stable patients.
Meticulous transthoracic echocardiogram follow up
for mechanical valves with low threshold transesophageal echocardiogram for patients with
elevated gradient is recommended.
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